Real-world clinical evaluation of natural and induced vasomotor symptoms in the USA and Europe

References

• Nappi RE, Kroll R, Siddiqui E, et al. Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden. Menopause. 2021;28(8):875–882. doi: 10.1097/GME.0000000000001793.
   PubMed Web of Science ®Google Scholar
• Hill K. The demography of menopause. Maturitas. 1996;23(2):113–127. doi: 10.1016/0378-5122(95)00968-x.
   PubMed Web of Science ®Google Scholar
• Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15–23. doi: 10.1016/j.breast.2022.08.010.
   PubMed Web of Science ®Google Scholar
• Stearns V, Ullmer L, López JF, et al. Hot flushes. Lancet. 2002;360(9348):1851–1861. doi: 10.1016/s0140-6736(02)11774-0.
   PubMed Web of Science ®Google Scholar
• Cole KM, Clemons M, Alzahrani M, et al. Vasomotor symptoms in early breast cancer – a “real world” exploration of the patient experience. Support Care Cancer. 2022;30(5):4437–4446. doi: 10.1007/s00520-022-06848-3.
   PubMed Web of Science ®Google Scholar
• Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes. 2005;3(1):47. doi: 10.1186/1477-7525-3-47.
   PubMedGoogle Scholar
• Williams RE, Kalilani L, DiBenedetti DB, et al. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric. 2008;11(1):32–43. doi: 10.1080/13697130701744696.
   PubMed Web of Science ®Google Scholar
• Williams RE, Levine KB, Kalilani L, et al. Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life. Maturitas. 2009;62(2):153–159. doi: 10.1016/j.maturitas.2008.12.006.
   PubMed Web of Science ®Google Scholar
• English M, Stoykova B, Slota C, et al. Qualitative study: burden of menopause-associated vasomotor symptoms (VMS) and validation of PROMIS sleep disturbance and sleep-related impairment measures for assessment of VMS impact on sleep. J Patient Rep Outcomes. 2021;5(1):42. doi: 10.1186/s41687-021-00322-0.
   PubMedGoogle Scholar
• Marino JL, Saunders CM, Emery LI, et al. Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history. Menopause. 2014;21(3):267–274. doi: 10.1097/GME.0b013e3182976f46.
   PubMed Web of Science ®Google Scholar
• Kingsberg S, Nappi RE, Scott M, et al. Physician and patient alignment on menopause-associated symptom burden and treatment decisions: RWE from Europe and the US. Climacteric. 2024 [Manuscript submitted for publication].
   Google Scholar
• Anderson P, Benford M, Harris N, et al. Real-world physician and patient behaviour across countries: disease-specific programmes – a means to understand. Curr Med Res Opin. 2008;24(11):3063–3072. doi: 10.1185/03007990802457040.
   PubMed Web of Science ®Google Scholar
• Babineaux SM, Curtis B, Holbrook T, et al. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the disease specific programme. BMJ Open. 2016;6(8):e010352. doi: 10.1136/bmjopen-2015-010352.
   PubMed Web of Science ®Google Scholar
• Radtke JV, Terhorst L, Cohen SM. The menopause-specific quality of life questionnaire: psychometric evaluation among breast cancer survivors. Menopause. 2011;18(3):289–295. doi: 10.1097/gme.0b013e3181ef975a.
   PubMed Web of Science ®Google Scholar
• Hilditch JR, Lewis J, Peter A, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 2008;61(1–2):107–121. doi: 10.1016/j.maturitas.2008.09.014.
   PubMed Web of Science ®Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365. doi: 10.2165/00019053-199304050-00006.
   PubMed Web of Science ®Google Scholar
• Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the menopause-specific quality of life questionnaire and development of a modified version, MENQOL-Intervention questionnaire. Maturitas. 2005;50(3):209–221. doi: 10.1016/j.maturitas.2004.06.015.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Guidance for industry: estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms: recommendations for clinical evaluation. In: Administration UFaD, editor; 2003.
   Google Scholar
• StataCorp. Stata statistical software: release 17. College Station (TX): StataCorp LLC; 2021.
   Google Scholar
• Nappi RE, Siddiqui E, Todorova L, et al. Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: a European cross-sectional survey. Maturitas. 2023; Jan167:66–74. doi: 10.1016/j.maturitas.2022.09.006.
   PubMed Web of Science ®Google Scholar
• Thurston RC, Bromberger JT, Joffe H, et al. Beyond frequency: Who is most bothered by vasomotor symptoms? Menopause. 2008;15(5):841–847. doi: 10.1097/gme.0b013e318168f09b.
   PubMed Web of Science ®Google Scholar
• DePree B, Shiozawa A, King D, et al. Association of menopausal vasomotor symptom severity with sleep and work impairments: a US survey. Menopause. 2023;30(9):887–897. doi: 10.1097/GME.0000000000002237.
   PubMed Web of Science ®Google Scholar
• Tomida M, Otsuka R, Tange C, et al. Vasomotor symptoms, sleep problems, and depressive symptoms in community‐dwelling Japanese women. J Obstet Gynaecol Res. 2021;47(10):3677–3690. doi: 10.1111/jog.14937.
   PubMed Web of Science ®Google Scholar
• Baker FC, De Zambotti M, Colrain IM, et al. Sleep problems during the menopausal transition: prevalence, impact, and management challenges. Nat Sci Sleep. 2018;10:73–95. doi: 10.2147/NSS.S125807.
   PubMed Web of Science ®Google Scholar
• Vousoura E, Spyropoulou AC, Koundi KL, et al. Vasomotor and depression symptoms may be associated with different sleep disturbance patterns in postmenopausal women. Menopause. 2015;22(10):1053–1057. doi: 10.1097/GME.0000000000000442.
   PubMed Web of Science ®Google Scholar
• Baker FC, Willoughby AR, Sassoon SA, et al. Insomnia in women approaching menopause: beyond perception. Psychoneuroendocrinology. 2015;60:96–104. doi: 10.1016/j.psyneuen.2015.06.005.
   PubMed Web of Science ®Google Scholar
• Caruso D, Masci I, Cipollone G, et al. Insomnia and depressive symptoms during the menopausal transition: theoretical and therapeutic implications of a self-reinforcing feedback loop. Maturitas. 2019;123:78–81. doi: 10.1016/j.maturitas.2019.02.007.
   PubMed Web of Science ®Google Scholar
• Collin LJ, Cronin-Fenton DP, Ahern TP, et al. Early discontinuation of endocrine therapy and recurrence of breast cancer among premenopausal women. Clin Cancer Res. 2021;27(5):1421–1428. doi: 10.1158/1078-0432.CCR-20-3974.
   PubMed Web of Science ®Google Scholar
• Rosso R, D’Alonzo M, Bounous VE, et al. Adherence to adjuvant endocrine therapy in breast cancer patients. Curr Oncol. 2023;30(2):1461–1472. doi: 10.3390/curroncol30020112.
   PubMed Web of Science ®Google Scholar
• Sella T, Zheng Y, Rosenberg SM, et al. Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors. NPJ Breast Cancer. 2023;9(1):31. doi: 10.1038/s41523-023-00529-y.
   PubMed Web of Science ®Google Scholar
• Chang C-H, Huang C-W, Huang C-M, et al. The duration of endocrine therapy and breast cancer patients’ survival. Medicine. 2019;98(43):e17746. doi: 10.1097/MD.0000000000017746.
   PubMed Web of Science ®Google Scholar
• Macpherson BE, Quinton ND. Menopause and healthcare professional education: a scoping review. Maturitas. 2022;166:89–95. doi: 10.1016/j.maturitas.2022.08.009.
   PubMed Web of Science ®Google Scholar
• Allen JT, Laks S, Zahler-Miller C, et al. Needs assessment of menopause education in United States obstetrics and gynecology residency training programs. Menopause. 2023;30(10):1002–1005. doi: 10.1097/GME.0000000000002234.
   PubMed Web of Science ®Google Scholar
• Faubion SS, Shufelt C. The menopause management vacuum. Cancer J. 2022;28(3):191–195. doi: 10.1097/PPO.0000000000000594.
   PubMed Web of Science ®Google Scholar
• Kling JM, MacLaughlin KL, Schnatz PF, et al. Menopause management knowledge in postgraduate family medicine, internal medicine, and obstetrics and gynecology residents: a cross-sectional survey. Mayo Clin Proc. 2019;94(2):242–253. doi: 10.1016/j.mayocp.2018.08.033.
   PubMed Web of Science ®Google Scholar
• Manson JE, Kaunitz AM. Menopause management – getting clinical care back on track. N Engl J Med. 2016; 2016/03/03374(9):803–806. 806. doi: 10.1056/NEJMp1514242.
   PubMed Web of Science ®Google Scholar
• Harper JC, Phillips S, Biswakarma R, et al. An online survey of perimenopausal women to determine their attitudes and knowledge of the menopause. Womens Health. 2022;18:174550572211068. doi: 10.1177/17455057221106890.
   Web of Science ®Google Scholar
• Lensen S, Archer D, Bell RJ, et al. A core outcome set for vasomotor symptoms associated with menopause: the COMMA (core outcomes in menopause) global initiative. Menopause. 2021;28(8):852–858. doi: 10.1097/GME.0000000000001787.
   PubMed Web of Science ®Google Scholar
• Peng Y, Wu T, Chen Z, et al. Value cocreation in health care: systematic review. J Med Internet Res. 2022;24(3):e33061. doi: 10.2196/33061.
   PubMed Web of Science ®Google Scholar